DEPO PROVERA 1000mg/6.7ml Price

Overview

Welcome to Dwaey, specifically on DEPO PROVERA 1000mg/6.7ml Injection page.
This medicine contains an important and useful components, as it consists of Medroxyprogesterone acetate.
DEPO PROVERA 1000mg/6.7ml is available in the market in concentration 150mg/ml and in the form of Injection.

PHARMACIA N.V/S.A. is the producer of DEPO PROVERA 1000mg/6.7ml and it is imported from BELGIUM, The most popular alternatives of DEPO PROVERA 1000mg/6.7ml are listed downward .

Mode Of Action

Atenolol is a beta-blocker that acts preferentially on the ?1 adrenergic receptors in the heart. Chlorthalidone is a thiazide-like diuretic that reduces BP possibly by inhibiting sodium reabsorption at the beginning of the distal convulated tubule. Combination of the two drugs results in additive antihypertensive action.

Indication

• Hypertension

Precaution

Bronchospastic disease, renal or hepatic impairment, elderly. May aggravate peripheral arterial circulatory disorder. Beta-blocker can depress myocardial contractility; continued use in patients without history of cardiac failure may in some cases, lead to cardiac failure. Caution in patients receiving anaesthetic agents that may depress myocardium. In patients with coronary artery disease, abrupt withdrawal may cause angina pectoris exacerbation, MI. Atenolol may mask signs (tachycardia) of hypoglycaemia and thyrotoxicosis. Latent DM may manifest with Chlorthalidone therapy. Chlorthalidone can cause hyperuricaemia and precipitate gout. Monitor renal functions, potassium levels, and signs of fluid and electrolytes imbalance. Discontinue if progressive renal impairment is evident. Not recommended in pregnancy and lactation. Safety and efficacy in paediatric patients have not been established. Lactation: excreted in breast milk, use caution

Side Effects

• Atenolol: Dyspnoea
• wheeziness
• bradycardia
• hypotension
• cold extremities
• fatigue
• dizziness
• insomnia
• lethargy
• confusion
• headache
• depression
• nightmares
• nausea
• diarrhoea
• constipation
• impotence
• paraesthesia
• rash
• Raynaud's phenomenon. Chlorthalidone: Orthostatic hypotension
• GI disturbances
• jaundice
• pancreatitis
• vertigo
• lethargy
• paraesthesia
• photosensitivity
• rash
• muscle cramps
• hypokalaemia
• hyponatraemia
• hyperglycaemia
• hyperuricaemia or gout
• leucopenia
• agranulocytosis
• aplastic anaemia
• thrombocytopenia. Potentially Fatal: Atenolol: Heart failure
• 2nd or 3rd degree AV block. Chlorthalidone: Hypersensitivity reaction including toxic epidermal necrolysis.

Contra indication

Sinus bradycardia, 2nd or 3rd degree heart block, cardiogenic shock, anuria, hypersentivity to either product or sulphonamide derivatives.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.